|
1
|
Mc Namara K, Alzubaidi H and Jackson JK:
Cardiovascular disease as a leading cause of death: How are
pharmacists getting involved? Integr Pharm Res Pract. 8:1–11. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hearse DJ and Bolli R: Reperfusion induced
injury: Manifestations, mechanisms, and clinical relevance.
Cardiovasc Res. 26:101–108. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yu LN, Yu J, Zhang FJ, Yang MJ, Ding TT,
Wang JK, He W, Fang T, Chen G and Yan M: Sevoflurane
postconditioning reduces myocardial reperfusion injury in rat
isolated hearts via activation of PI3K/Akt signaling and modulation
of Bcl-2 family proteins. J Zhejiang Univ Sci B. 11:661–672. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen Q, Xu T, Li D, Pan D, Wu P, Luo Y, Ma
Y and Liu Y: JNK/PI3K/Akt signaling pathway is involved in
myocardial ischemia/reperfusion injury in diabetic rats: Effects of
salvianolic acid A intervention. Am J Transl Res. 8:2534–2548.
2016.PubMed/NCBI
|
|
5
|
Zhao MM, Yang JY, Wang XB, Tang CS, Du JB
and Jin HF: The PI3K/Akt pathway mediates the protection of SO(2)
preconditioning against myocardial ischemia/reperfusion injury in
rats. Acta Pharmacol Sin. 34:501–506. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Vassalli G, Milano G and Moccetti T: Role
of mitogen-activated protein kinases in myocardial
ischemia-reperfusion injury during heart transplantation. J
Transplant. 2012:9289542012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Furuno M, Pang KC, Ninomiya N, Fukuda S,
Frith MC, Bult C, Kai C, Kawai J, Carninci P, Hayashizaki Y, et al:
Clusters of internally primed transcripts reveal novel long
noncoding RNAs. PLoS Genet. 2:e372006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hou J, Zhou C, Long H, Zheng S, Guo T, Wu
Q, Wu H, Zhong T and Wang T: Long noncoding RNAs: Novel molecules
in cardiovascular biology, disease and regeneration. Exp Mol
Pathol. 100:493–501. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li L, Feng T, Lian Y, Zhang G, Garen A and
Song X: Role of human noncoding RNAs in the control of
tumorigenesis. Proc Natl Acad Sci USA. 106:12956–12961. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Whitehead J, Pandey GK and Kanduri C:
Regulation of the mammalian epigenome by long noncoding RNAs.
Biochim Biophys Acta. 1790:936–947. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kumar MM and Goyal R: LncRNA as a
therapeutic target for angiogenesis. Curr Top Med Chem.
17:1750–1757. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhao J, Du P, Cui P, Qin Y, Hu C, Wu J,
Zhou Z, Zhang W, Qin L and Huang G: LncRNA PVT1 promotes
angiogenesis via activating the STAT3/VEGFA axis in gastric cancer.
Oncogene. 37:4094–4109. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gabory A, Jammes H and Dandolo L: The H19
locus: Role of an imprinted non-coding RNA in growth and
development. Bioessays. 32:473–480. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rajagopalan V, Zhang Y, Pol C, Costello C,
Seitter S, Lehto A, Savinova OV, Chen YF and Gerdes AM: Modified
low-dose triiodo-L-thyronine therapy safely improves function
following myocardial ischemia-reperfusion injury. Front Physiol.
8:2252017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang X, Cheng L, Xu L, Zhang Y, Yang Y,
Fu Q, Mi W and Li H: The Lncrna, H19 mediates the protective effect
of hypoxia postconditioning against hypoxia-reoxygenation injury to
senescent cardiomyocytes by targeting microRNA-29b-3p. Shock.
52:249–256. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhu HM and Deng L: Evaluation of
cardiomyocyte hypoxia injury models for the pharmacological study
in vitro. Pharm Biol. 50:167–174. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gong LC, Xu HM, Guo GL, Zhang T, Shi JW
and Chang C: Long non-coding RNA H19 protects H9c2 cells against
hypoxia-induced injury by targeting microRNA-139. Cell Physiol
Biochem. 44:857–869. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li H, Yu B, Li J, Su L, Yan M, Zhu Z and
Liu B: Overexpression of lncRNA H19 enhances carcinogenesis and
metastasis of gastric cancer. Oncotarget. 5:2318–2329. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lottin S, Adriaenssens E, Dupressoir T,
Berteaux N, Montpellier C, Coll J, Dugimont T and Curgy JJ:
Overexpression of an ectopic H19 gene enhances the tumorigenic
properties of breast cancer cells. Carcinogenesis. 23:1885–1895.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li C, Tian J, Li G, Jiang W, Xing Y, Hou
J, Zhu H, Xu H, Zhang G, Liu Z and Ye Z: Asperosaponin VI protects
cardiac myocytes from hypoxia-induced apoptosis via activation of
the PI3K/Akt and CREB pathways. Eur J Pharmacol. 649:100–107. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lin KH, Kuo WW, Jiang AZ, Pai P, Lin JY,
Chen WK, Day CH, Shen CY, Padma VV and Huang CY:
Tetramethylpyrazine ameliorated hypoxia-induced myocardial cell
apoptosis via HIF-1α/JNK/p38 and IGFBP3/BNIP3 inhibition to
upregulate PI3K/Akt survival signaling. Cell Physiol Biochem.
36:334–344. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xiao J, Zhu X, Kang B, Xu J, Wu L, Hong J,
Zhang Y, Ni X and Wang Z: Hydrogen sulfide attenuates myocardial
hypoxia-reoxygenation injury by inhibiting autophagy via mTOR
activation. Cell Physiol Biochem. 37:2444–2453. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen XQ, Wu SH, Zhou Y and Tang YR:
Lipoxin A4-induced heme oxygenase-1 protects cardiomyocytes against
hypoxia/reoxygenation injury via p38 MAPK activation and Nrf2/ARE
complex. PLoS One. 8:e671202013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang B, Shravah J, Luo H, Raedschelders K,
Chen DD and Ansley DM: Propofol protects against hydrogen
peroxide-induced injury in cardiac H9c2 cells via Akt activation
and Bcl-2 up-regulation. Biochem Biophys Res Commun. 389:105–111.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Edlich F: BCL-2 proteins and apoptosis:
Recent insights and unknowns. Biochem Biophys Res Commun.
500:26–34. 2018. View Article : Google Scholar : PubMed/NCBI
|
